Unknown

Dataset Information

0

Activation of plasmacytoid dendritic cells promotes AML-cell fratricide.


ABSTRACT: Acute myeloid leukemia (AML) is characterized by the proliferation of immature myeloid blasts and a suppressed immune state. Interferons have been previously shown to aid in the clearance of AML cells. Type I interferons are produced primarily by plasmacytoid dendritic cells (pDCs). However, these cells exist in a quiescent state in AML. Because pDCs express TLR 7-9, we hypothesized that the TLR7/8 agonist R848 would be able to reprogram them toward a more active, IFN-producing phenotype. Consistent with this notion, we found that R848-treated pDCs from patients produced significantly elevated levels of IFNβ. In addition, they showed increased expression of the immune-stimulatory receptor CD40. We next tested whether IFNβ would influence antibody-mediated fratricide among AML cells, as our recent work showed that AML cells could undergo cell-to cell killing in the presence of the CD38 antibody daratumumab. We found that IFNβ treatment led to a significant, IRF9-dependent increase in CD38 expression and a subsequent increase in daratumumab-mediated cytotoxicity and decreased colony formation. These findings suggest that the tolerogenic phenotype of pDCs in AML can be reversed, and also demonstrate a possible means of enhancing endogenous Type I IFN production that would promote daratumumab-mediated clearance of AML cells.

SUBMITTER: Fatehchand K 

PROVIDER: S-EPMC8092344 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4048786 | biostudies-literature
| S-EPMC10133850 | biostudies-literature
| S-EPMC7502826 | biostudies-literature
| S-EPMC1895464 | biostudies-literature
| S-EPMC5649186 | biostudies-literature
| S-EPMC5309800 | biostudies-literature
| S-EPMC9570010 | biostudies-literature
| S-EPMC7851743 | biostudies-literature
| S-EPMC6898719 | biostudies-literature
2020-09-14 | PXD019239 | Pride